254 related articles for article (PubMed ID: 9845395)
1. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies).
Talley NJ; Meineche-Schmidt V; Paré P; Duckworth M; Räisänen P; Pap A; Kordecki H; Schmid V
Aliment Pharmacol Ther; 1998 Nov; 12(11):1055-65. PubMed ID: 9845395
[TBL] [Abstract][Full Text] [Related]
2. Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients.
Wong WM; Wong BC; Hung WK; Yee YK; Yip AW; Szeto ML; Fung FM; Tong TS; Lai KC; Hu WH; Yuen MF; Lam SK
Gut; 2002 Oct; 51(4):502-6. PubMed ID: 12235071
[TBL] [Abstract][Full Text] [Related]
3. Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group.
Blum AL; Arnold R; Stolte M; Fischer M; Koelz HR
Gut; 2000 Oct; 47(4):473-80. PubMed ID: 10986206
[TBL] [Abstract][Full Text] [Related]
4. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group.
Talley NJ; Janssens J; Lauritsen K; Rácz I; Bolling-Sternevald E
BMJ; 1999 Mar; 318(7187):833-7. PubMed ID: 10092259
[TBL] [Abstract][Full Text] [Related]
5. Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia.
Hsu PI; Lai KH; Tseng HH; Lo GH; Lo CC; Lin CK; Cheng JS; Chan HH; Ku MK; Peng NJ; Chien EJ; Chen W; Hsu PN
Aliment Pharmacol Ther; 2001 Feb; 15(2):195-201. PubMed ID: 11148437
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
Koskenpato J; Farkkilä M; Sipponen P
Am J Gastroenterol; 2001 Oct; 96(10):2866-72. PubMed ID: 11693319
[TBL] [Abstract][Full Text] [Related]
7. Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial.
Bolling-Sternevald E; Lauritsen K; Aalykke C; Havelund T; Knudsen T; Unge P; Ekström P; Jaup B; Norrby A; Stubberöd A; Melén K; Carlsson R; Jerndal P; Junghard O; Glise H
Scand J Gastroenterol; 2002 Dec; 37(12):1395-402. PubMed ID: 12523588
[TBL] [Abstract][Full Text] [Related]
8. Does the 'test-and-treat' strategy work in primary health care for management of uninvestigated dyspepsia? A prospective two-year follow-up study of 1552 patients.
Färkkilä M; Sarna S; Valtonen V; Sipponen P;
Scand J Gastroenterol; 2004 Apr; 39(4):327-35. PubMed ID: 15125464
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up.
Koelz HR; Arnold R; Stolte M; Fischer M; Blum AL;
Gut; 2003 Jan; 52(1):40-6. PubMed ID: 12477757
[TBL] [Abstract][Full Text] [Related]
10. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
Peura DA; Kovacs TO; Metz DC; Siepman N; Pilmer BL; Talley NJ
Am J Med; 2004 Jun; 116(11):740-8. PubMed ID: 15144910
[TBL] [Abstract][Full Text] [Related]
11. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.
Blum AL; Talley NJ; O'Moráin C; van Zanten SV; Labenz J; Stolte M; Louw JA; Stubberöd A; Theodórs A; Sundin M; Bolling-Sternevald E; Junghard O
N Engl J Med; 1998 Dec; 339(26):1875-81. PubMed ID: 9862942
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of omeprazole-based short-term triple therapy in Helicobacter pylori-positive older patients with dyspepsia.
Moshkowitz M; Brill S; Konikoff FM; Reif S; Arber N; Halpern Z
J Am Geriatr Soc; 1999 Jun; 47(6):720-2. PubMed ID: 10366173
[TBL] [Abstract][Full Text] [Related]
13. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.
Talley NJ; Vakil N; Ballard ED; Fennerty MB
N Engl J Med; 1999 Oct; 341(15):1106-11. PubMed ID: 10511608
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia.
Froehlich F; Gonvers JJ; Wietlisbach V; Burnand B; Hildebrand P; Schneider C; Saraga E; Beglinger C; Vader JP;
Am J Gastroenterol; 2001 Aug; 96(8):2329-36. PubMed ID: 11513170
[TBL] [Abstract][Full Text] [Related]
15. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.
Labenz J; Blum AL; Bolten WW; Dragosics B; Rösch W; Stolte M; Koelz HR
Gut; 2002 Sep; 51(3):329-35. PubMed ID: 12171952
[TBL] [Abstract][Full Text] [Related]
16. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.
McColl K; Murray L; El-Omar E; Dickson A; El-Nujumi A; Wirz A; Kelman A; Penny C; Knill-Jones R; Hilditch T
N Engl J Med; 1998 Dec; 339(26):1869-74. PubMed ID: 9862941
[TBL] [Abstract][Full Text] [Related]
17. Patients with functional dyspepsia responding to omeprazole have a characteristic gastro-oesophageal reflux pattern.
Farup PG; Hovde O; Torp R; Wetterhus S
Scand J Gastroenterol; 1999 Jun; 34(6):575-9. PubMed ID: 10440606
[TBL] [Abstract][Full Text] [Related]
18. [Effect of the Helicobacter pylori eradication in patients with functional dyspepsia: randomised placebo-controlled trial].
Ruiz García A; Gordillo López FJ; Hermosa Hernán JC; Arranz Martínez E; Villares Rodríguez JE
Med Clin (Barc); 2005 Mar; 124(11):401-5. PubMed ID: 15799844
[TBL] [Abstract][Full Text] [Related]
19. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group.
Moayyedi P; Feltbower R; Brown J; Mason S; Mason J; Nathan J; Richards ID; Dowell AC; Axon AT
Lancet; 2000 May; 355(9216):1665-9. PubMed ID: 10905240
[TBL] [Abstract][Full Text] [Related]
20. Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia?
Bolling-Sternevald E; Lauritsen K; Talley NJ; Junghard O; Glise H
Aliment Pharmacol Ther; 2003 Jul; 18(1):117-24. PubMed ID: 12848633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
